These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30684458)

  • 1. Exploring electrostatic interactions of relaxin family peptide receptor 3 and 4 with ligands using a NanoBiT-based binding assay.
    Wang JH; Nie WH; Shao XX; Li HZ; Hu MJ; Liu YL; Xu ZG; Guo ZY
    Biochim Biophys Acta Biomembr; 2019 Apr; 1861(4):776-786. PubMed ID: 30684458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The electrostatic interactions of relaxin-3 with receptor RXFP4 and the influence of its B-chain C-terminal conformation.
    Wang XY; Guo YQ; Zhang WJ; Shao XX; Liu YL; Xu ZG; Guo ZY
    FEBS J; 2014 Jul; 281(13):2927-36. PubMed ID: 24802387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring receptor selectivity of the chimeric relaxin family peptide R3/I5 by incorporating unnatural amino acids.
    Wang JH; Hu MJ; Zhang L; Shao XX; Lv CH; Liu YL; Xu ZG; Guo ZY
    Biochimie; 2018 Nov; 154():77-85. PubMed ID: 30102931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a novel ligand binding assay for relaxin family peptide receptor 3 and 4 using NanoLuc complementation.
    Hu MJ; Shao XX; Li HZ; Nie WH; Wang JH; Liu YL; Xu ZG; Guo ZY
    Amino Acids; 2018 Aug; 50(8):1111-1119. PubMed ID: 29770870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a selective agonist for relaxin family peptide receptor 3.
    Wei D; Hu MJ; Shao XX; Wang JH; Nie WH; Liu YL; Xu ZG; Guo ZY
    Sci Rep; 2017 Jun; 7(1):3230. PubMed ID: 28607363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrophobic interactions of relaxin family peptide receptor 3 with ligands identified using a NanoBiT-based binding assay.
    Li HZ; Li N; Shao XX; Liu YL; Xu ZG; Guo ZY
    Biochimie; 2020 Oct; 177():117-126. PubMed ID: 32810565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays.
    Wu H; Hoare BL; Handley TNG; Akhter Hossain M; Bathgate RAD
    Biochem Pharmacol; 2024 Jun; 224():116238. PubMed ID: 38677442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid preparation of bioluminescent tracers for relaxin family peptides using sortase-catalysed ligation.
    Wang JH; Shao XX; Hu MJ; Wei D; Nie WH; Liu YL; Xu ZG; Guo ZY
    Amino Acids; 2017 Sep; 49(9):1611-1617. PubMed ID: 28631012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of important residues of insulin-like peptide 5 and its receptor RXFP4 for ligand-receptor interactions.
    Wang XY; Guo YQ; Shao XX; Liu YL; Xu ZG; Guo ZY
    Arch Biochem Biophys; 2014 Sep; 558():127-32. PubMed ID: 25043977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functionality of an absolutely conserved glycine residue in the chimeric relaxin family peptide R3/I5.
    Wang JH; Shao XX; Hu MJ; Liu YL; Xu ZG; Guo ZY
    Amino Acids; 2019 Apr; 51(4):619-626. PubMed ID: 30604098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structural and functional role of the B-chain C-terminal arginine in the relaxin-3 peptide antagonist, R3(BDelta23-27)R/I5.
    Hossain MA; Bathgate RA; Rosengren KJ; Shabanpoor F; Zhang S; Lin F; Tregear GW; Wade JD
    Chem Biol Drug Des; 2009 Jan; 73(1):46-52. PubMed ID: 19152634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The highly conserved negatively charged Glu141 and Asp145 of the G-protein-coupled receptor RXFP3 interact with the highly conserved positively charged arginine residues of relaxin-3.
    Zhang WJ; Wang XY; Guo YQ; Luo X; Gao XJ; Shao XX; Liu YL; Xu ZG; Guo ZY
    Amino Acids; 2014 May; 46(5):1393-402. PubMed ID: 24615237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A convenient method for europium-labeling of a recombinant chimeric relaxin family peptide R3/I5 for receptor-binding assays.
    Zhang WJ; Jiang Q; Wang XY; Song G; Shao XX; Guo ZY
    J Pept Sci; 2013 Jun; 19(6):350-4. PubMed ID: 23526726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of hydrophobic interactions between relaxin-3 and its receptor RXFP3: implication for a conformational change in the B-chain C-terminus during receptor binding.
    Hu MJ; Shao XX; Wang JH; Wei D; Liu YL; Xu ZG; Guo ZY
    Amino Acids; 2016 Sep; 48(9):2227-36. PubMed ID: 27193232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
    Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T
    Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct but overlapping binding sites of agonist and antagonist at the relaxin family peptide 3 (RXFP3) receptor.
    Wong LLL; Scott DJ; Hossain MA; Kaas Q; Rosengren KJ; Bathgate RAD
    J Biol Chem; 2018 Oct; 293(41):15777-15789. PubMed ID: 30131340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism for insulin-like peptide 5 distinguishing the homologous relaxin family peptide receptor 3 and 4.
    Hu MJ; Shao XX; Wang JH; Wei D; Guo YQ; Liu YL; Xu ZG; Guo ZY
    Sci Rep; 2016 Jul; 6():29648. PubMed ID: 27404393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the novel bioluminescent ligand-receptor binding assay to relaxin-RXFP1 system for interaction studies.
    Wu QP; Zhang L; Shao XX; Wang JH; Gao Y; Xu ZG; Liu YL; Guo ZY
    Amino Acids; 2016 Apr; 48(4):1099-1107. PubMed ID: 26767372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.
    Halls ML; van der Westhuizen ET; Bathgate RA; Summers RJ
    Br J Pharmacol; 2007 Mar; 150(6):677-91. PubMed ID: 17293890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-specific DOTA/europium-labeling of recombinant human relaxin-3 for receptor-ligand interaction studies.
    Zhang WJ; Luo X; Liu YL; Shao XX; Wade JD; Bathgate RA; Guo ZY
    Amino Acids; 2012 Aug; 43(2):983-92. PubMed ID: 22187146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.